IL6 and COVID-19: In summary, IL-6 plays a pivotal role in the establishment of a hyperinflammatory milieu that leads to ARDS in patients with severe COVID-19, since it controls the transcription of various cytokines and growth factors involved in inflammation and fibrosis.